NL-OMON26626已完成不适用
Corona Research Limburg
GGD South Limburg0 个研究点目标入组 10,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10,000
研究概览
简要总结
ot yet available
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •18 years and older and residence in Limburg, Nethetrlands
排除标准
- •younger than 18 years or no residence in Limburg
研究者
相似试验
已完成
不适用
Corona Research LimburgCorona antibodiesSARS-CoV-2 antibodies10047438NL-OMON49431GGD Zuid Limburg10,000
招募中
不适用
Development of health information communication strategy in response to COVID-19 crisisEndocrine, nutritional and metabolic diseasesKCT0006945Korea National Open University2,000
已完成
2 期
Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 PneumoniaCOVID-19NCT04445272Fundacion SEIMC-GESIDA495
已完成
不适用
Corona (COVID-19): outbreak-related examinations in childcare centers - COALACoronavirus disease 2019 (COVID-19)U07.1COVID-19, virus identifiedDRKS00023501Robert Koch-Institut943
终止
2 期
Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 PatientsCOVID-19 Virus InfectionNCT04449380Emanuele Bosi56